AlphaValue Corporate Services Fundamental Analysis FR
Back to
AlphaValue Corporate Services

Europlasma

CR
Bloomberg   ALEUP FP
Alternative Energy  /  France  Web Site   |   Investors Relation
Time to press the power on switch
Pros
  • Europlasma is part of a handful of companies worldwide able to master plasma torches in fields that span emission control and green energy provision
  • The use of plasma torches to better the performance of waste-to-power processes provides Europlasma with an ace when it comes to efficiency
  • Europlasma has a unique market position in its capability to deal with abestos waste
Cons
  • By investing to capture the value attached to plasma-based processes, Europlasma has stretched itself and stumbled on funding issues. Costly refinancing exercises have been a drain on management's time
  • Europlasma may end up selling one of its businesses to fund the others
Updates
29/01/19OpinionCall Option vs Buy
28/01/19 Financing i...Europlasma files for Chapter 11
11/12/18 Other newsA tighter spot
21/11/18 EarningsPower generation fine-tuning at a further ...
21/11/18 TargetThe small new energy group is suffering f...
21/11/18 EPSEPS suffers from the H1 18 loss, meanin...
21/11/18 NAVThe lower NAV per share recognises a hi...
21/11/18 DCFThe lower DCF recognises a higher forwa...
12/09/18 StrategyOrano as big bro'
26/07/18 Financing i...Europlasma bridges delays with costly eq...
30/05/18 TargetThe 2017 earnings recognize additional l...
30/05/18 EPS2017 EPS allow for deeper losses, financ...
30/05/18 NAVThe NAV allows for the extra funding cost...
30/05/18 DCFThe DCF is mainly a best effort type proje...
10/04/18 TargetEuroplasma's business model change, w...
10/04/18 EPSChanges to 2018 earnings are not releva...
10/04/18 NAVThe update in our NAV recognises the va...
10/04/18 DCFSales and cash flow will be "power"-drive...
27/03/18 StrategyA most welcomed simplification
28/02/18 Other newsPlasma to help clean up steelmaking
12/02/18 Financing i...Fresh and less expensive round of financ...
01/02/18 TargetThe sharp drop in the target price is due t...
01/02/18 EPSUpdates to fragile forecasting models an...
01/02/18 NAVAn overdue set of adjustments which co...
01/02/18 DCFAn overdue set of adjustments which co...
15/11/17 EarningsFurther pain by H1 17 but green energy p...
05/05/17 Other news2016's considerable pains open the way t...
05/11/16 EarningsCash drain continues by H1, ends by 201...
05/11/16 EPS2016 FY earnings now allow for the heav...
05/11/16 NAVOur NAV erodes due to cash consumptio...
05/11/16 DCFThe DCF is impacted by the cash consu...
26/09/16 TargetThe sharp drop in target price combines t...
26/09/16 EPS2016 was not expected to be a great year...
26/09/16 NAVOur NAV tries to recognise the value of th...
26/09/16 DCFA DCF primarily embarks on the long-ter...
09/03/16 EarningsLiquidity sorted and good revenues on n...
10/06/15OpinionThe target price is lowered after taking on...
10/06/15 EPSEPSs are driven by a recovery of the was...
10/06/15 NAVDelays in engineering work and delivery ...
10/06/15 DCFDiscounted cash flows suffer from pushin...
05/11/14 EarningsSuccessful capital increase, massive H1 ...
Target
Upside 376%
Price (€) 0.04
Market Cap (€M) 11.0
Perf. 1W: 30.2%
Perf. 1M: 14.5%
Perf. 3M: -23.6%
Perf Ytd: -29.8%
10 day relative perf. to stoxx600: 11.1%
20 day relative perf. to stoxx600: 10.7%
Overview
Value
Equity Risk
Governance
Ranking
Best
Europlasma
Utilities
Worst